Ana Arencibía (Ana Arencibia)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Disease Activity

Hepatitis C Virus Infection

Depressive Symptoms

Rheumatoid Arthritis Patients

Top Venues

Hepatology (Baltimore, Md.)

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics 60 (2) (2024)
Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics 60 (2) (2024)
Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics 60 (2) (2024)
Juan-Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, Adolfo Gallego Moya, Isabel Conde Amiel, Ana Arencibía, Moises Diago, Javier García-Samaniego, Jose Castellote, Susana Llerena, Elisa Rodríguez-Seguel, Beatriz Mateos, Manuel Rodríguez, Jose Miguel Rosales Zabal, Inmaculada Fernández, Jose Luis Calleja, Rosa María Morillas, Silvia Montoliu, Raúl Jesús Andrade, Ester Badia Aranda, Manuel Hernández Guerra, Carlota Jimeno Maté, Jesús M González-Santiago, Beatriz de Cuenca, Vanesa Bernal-Monterde, Manuel Delgado, Juan Turnes Vázquez, Sabela Lens, Maria Buti Ferret
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Alimentary pharmacology & therapeutics (2024)
Álvaro Díaz-González, Manuel Hernández Guerra, Indhira Pérez-Medrano, Víctor Sapena, Mar Riveiro, Ana Barreira Díaz, Elena Gómez, Rosa María Morillas, María Del Barrio, Laia Escudé, Beatriz Mateos, Diana Horta, Judith Gómez, Isabel Conde Amiel, Carlos Ferre, Ismael El Hajra, Ana Arencibía, Javier Manuel Zamora-Olaya, Ahinoa Fernández Moreno, Magdalena Salcedo Plaza, Esther Molina, Anna Soria, Pamela Estévez, Carmen López, Montserrat García-Retortillo, Javier Crespo, María Carlota Londoño, null null
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration. Hepatology (Baltimore, Md.) 77 (4) (2023)
Álvaro Díaz-González, Manuel Hernández Guerra, Indhira Pérez-Medrano, Víctor Sapena, Mar Riveiro, Ana Barreira Díaz, Elena Gómez, Rosa María Morillas, María Del Barrio, Laia Escudé, Beatriz Mateos, Diana Horta, Judith Gómez, Isabel Conde Amiel, Carlos Ferre, Ismael El Hajra, Ana Arencibía, Javier Manuel Zamora-Olaya, Ahinoa Fernández Moreno, Magdalena Salcedo Plaza, Esther Molina, Anna Soria, Pamela Estévez, Carmen López, Montserrat García-Retortillo, Javier Crespo, María Carlota Londoño, null null
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration. Hepatology (Baltimore, Md.) (2023)
Álvaro Díaz-González, Manuel Hernández Guerra, Indhira Pérez-Medrano, Víctor Sapena, Mar Riveiro, Ana Barreira Díaz, Elena Gómez, Rosa María Morillas, María Del Barrio, Laia Escudé, Beatriz Mateos, Diana Horta, Judith Gómez, Isabel Conde Amiel, Carlos Ferre, Ismael El Hajra, Ana Arencibía, Javier Manuel Zamora-Olaya, Ahinoa Fernández Moreno, Magdalena Salcedo Plaza, Esther Molina, Anna Soria, Pamela Estévez, Carmen López, Montserrat García-Retortillo, Javier Crespo, María Carlota Londoño, null null
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration. Hepatology (Baltimore, Md.) (2023)
Álvaro Díaz-González, Manuel Hernández Guerra, Indhira Pérez-Medrano, Víctor Sapena, Mar Riveiro, Ana Barreira Díaz, Elena Gómez, Rosa María Morillas, María Del Barrio, Laia Escudé, Beatriz Mateos, Diana Horta, Judith Gómez, Isabel Conde Amiel, Carlos Ferre, Ismael El Hajra, Ana Arencibía, Javier Manuel Zamora-Olaya, Ahinoa Fernández Moreno, Magdalena Salcedo Plaza, Esther Molina, Anna Soria, Pamela Estévez, Carmen López, Montserrat García-Retortillo, Javier Crespo, María Carlota Londoño, null null
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration. Hepatology (Baltimore, Md.) 77 (4) (2023)
Álvaro Díaz-González, Manuel Hernández Guerra, Indhira Pérez-Medrano, Víctor Sapena, Mar Riveiro, Ana Barreira Díaz, Elena Gómez, Rosa María Morillas, María Del Barrio, Laia Escudé, Beatriz Mateos, Diana Horta, Judith Gómez, Isabel Conde Amiel, Carlos Ferre, Ismael El Hajra, Ana Arencibía, Javier Manuel Zamora-Olaya, Ahinoa Fernández Moreno, Magdalena Salcedo Plaza, Esther Molina, Anna Soria, Pamela Estévez, Carmen López, Montserrat García-Retortillo, Javier Crespo, María Carlota Londoño, null null
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration. Hepatology (Baltimore, Md.) 77 (4) (2023)